Role of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency virus type 1-associated dementia

European Journal of Clinical Investigation

Volumn 30, Issue 6, 2000, Pages 526-535

  Smits, H A ^b   Boven, L A ^b   Pereira, C F ^b   Verhoef, J ^b   Nottet, Hans S L M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Alzheimer's disease; Amyloid ; Astrocyte; Human immunodeficiency virus type 1 associated dementia; Macrophage; Signal transduction

Indexed keywords

AMYLOID BETA PROTEIN; CYTOKINE; NEUROTROPHIN; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ASTROCYTE; BRAIN NERVE CELL; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CELL STRUCTURE; DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MICROGLIA; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

AIDS DEMENTIA COMPLEX; ALZHEIMER DISEASE; HUMANS; MACROPHAGE ACTIVATION;

EID: 0000459735     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00661.x     Document Type: Review

References (105)

1. 1 Giulian D, Robertson C. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 1990;27:33-42.
2. 2 Stoll G, Trapp BD, Griffin JW. Macrophage function during Wallerian degeneration of rat optic nerve: clearance of degenerating myelin and Ia expression. J Neurosci 1989;9:2327-35.
3. 3 Sharer LR, Epstein LG, Cho ES, Joshi VV, Meyenhofer MF, Rankin LF et al. Pathologic features of AIDS encephalopathy in children: evidence for LAV/ HTLV-III infection of brain. Hum Pathol 1986;17:271-84.
4. 4 Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990;172:1025-33.
5. 5 Coffey PJ, Perry VH, Rawlins JN. An investigation into the early stages of the inflammatory response following ibotenic acid-induced neuronal degeneration. Neuroscience 1990;35:121-32.
6. 6 Li H, Newcombe J, Groome NP, Cuzner ML. Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol Appl Neurobiol 1993;19:214-23.
7. 7 McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988;38:1285-91.
8. 8 McGeer PL, Itagaki S, McGeer EG. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol Berl 1988;76:550-7.
9. 9 Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS, central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239:586-92.
10. 10 Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995;374:647-50.
11. 11 Brown DR, Schmidt B, Kretzschmar HA. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 1996;380:345-7.
12. 12 Muhleisen H, Gehrmann J, Meyermann R. Reactive microglia in Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1995;21:505-17.
13. 13 Barde YA. Trophic factors and neuronal survival. Neuron 1989;2:1525-34.
14. 14 Boven LA, Middel J, Portegies P, Verhoef J, Jansen GH, Nottet HS. Overexpression of nerve growth factor and basic fibroblast growth factor in AIDS dementia complex. J Neuroimmunol 1999;3690:154-62.
15. 15 McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
16. 16 Lendon CL, Ashall F, Goate AM. Exploring the etiology of Alzheimer disease using molecular genetics. J Am Med Assoc 1997;277:825-31.
17. 17 Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 1995;92: 4725-7.
18. 18 Cummings JL, Vinters HV, Cole GM, Khachaturian ZS. Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 1998;51:S2-17.
19. 19 Dickson DW. The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997;56:321-39.
20. 20 Schmidt ML, Lee VM, Forman M, Chiu TS, Trojanowski JQ. Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains. Am J Pathol 1997;151:69-80.
21. 21 Gendelman HE, Folks DG. Innate and acquired immunity in neurodegenerative disorders. J Leukoc Biol 1999;65: 407-8.
22. 22 Cotter RL, Burke WJ, Thomas VS, Potter JF, Zheng J, Gendelman HE. Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity. J Leukoc Biol 1999;65:416-27.
23. 23 McGeer PL, McGeer EG. Inflammation of the brain in Alzheimer's disease: implications for therapy. J Leukoc Biol 1999;65:409-15.
24. 24 Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur J Pharmacol 1991;207:367-8.
25. 25 Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 1990;250:279-82.
26. 26 Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994;77:817-27.
27. 27 Yaar M, Zhai S, Pilch PF, Doyle SM, Eisenhauer PB, Fine RE et al. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest 1997;100:2333-40.
28. 28 Davies P. Neuronal abnormalities, not amyloid, are the cause of dementia in Alzheimer's disease. In: Terry RD, Katzman R, Bick BK, editors. Alzheimer's Disease. New York: Raven Press;1994.p.327-33.
29. 29 Giulian D, Haverkamp LJ, Li J, Karshin WL, Yu J, Tom D et al. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 1995;27:119-37.
30. 30 McGeer EG, McGeer PL. The role of the immune system in neurodegenerative disorders. Mov Disord 1997;12:855-8.
31. 31 McGeer PL, McGeer EG, Kawamata T, Yamada T, Akiyama H. Reactions of the immune system in chronic degenerative neurological diseases. Can J Neurol Sci 1991;18:376-9.
32. 32 Rozemuller JM, Eikelenboom P, Stam FC. Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol 1986;51:247-54.
33. 33 Rozemuller JM, Eikelenboom P, Pals ST, Stam FC. Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family. Neurosci Lett 1989;101:288-92.
34. 34 Wisniewski HM, Wegiel J, Wang KG, Kujawa M, Lach B. Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can J Neurol Sci 1989;16:535-42.
35. 35 Lorton D, Kocsis JM, King L, Madden K, Brunden KR. beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes. J Neuroimmunol 1996;67:21-9.
36. 36 Klegeris A, Walker DG, McGeer PL. Interaction of Alzheimer beta-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-alpha. Brain Res 1997;747:114-21.
37. 37 Klegeris A, McGeer PL. beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J Neurosci Res 1997;49:229-35.
38. 38 Klegeris A, Walker DG, McGeer PL. Activation of macrophages by Alzheimer beta amyloid peptide. Biochem Biophys Res Commun 1994;199:984-91.
39. 39 McDonald DR, Brunden KR, Landreth GE. Amyloid Fibrils Activate Tyrosine Kinase-Dependent Signaling and Superoxide Production in Microglia. J Neurosci 1997;17:2284-94.
40. 40 Elkabes S, DiCicco Bloom EM, Black IB. Brain microglia/ macrophages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci 1996;16:2508-21.
41. 41 Giulian D, Haverkamp LJ, Yu JH, Karshin W, Tom D, Li J et al. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J Neurosci 1996;16:6021-37.
42. 42 Sinha S, Lieberburg I. Cellular mechanisms of beta-amyloid production and secretion. Proc Natl Acad Sci USA 1999;96:11049-53.
43. 43 McDonald DR, Bamberger ME, Combs CK, Landreth GE. beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J Neurosci 1998;18:4451-60.
44. 44 Combs CK, Johnson DE, Cannady SB, Lehman TM, Landreth GE. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J Neurosci 1999;19:928-39.
45. 45 Bonaiuto C, McDonald PP, Rossi F, Cassatella MA. Activation of nuclear factor-kappa B by beta-amyloid peptides and interferon-gamma in murine microglia. J Neuroimmunol 1997;77:51-6.
46. 46 Heese K, Hock C, Otten U. Inflammatory signals induce neurotrophin expression in human microglial cells. J Neurochem 1998;70:699-707.
47. 47 Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994;12:141-79.
48. 48 Meda L, Bonaiuto C, Baron P, Otvos L Jr, Rossi F, Cassatella MA. Priming of monocyte respiratory burst by beta-amyloid fragment (25-35). Neurosci Lett 1996;219: 91-4.
49. 49 Benna JE, Dang PM, Gaudry M, Fay M, Morel F, Hakim J et al. Phosphorylation of the respiratory burst oxidase subunit p67 (phox) during human neutrophil activation. Regulation by protein kinase C-dependent and independent pathways. J Biol Chem 1997;272:17204-8.
50. 50 Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease [see comments]. Nature 1996;382:685-91.
51. 51 Du Yan S, Zhu H, Fu J, Yan SF, Roher A, Tourtellotte WW et al. Amyloid-beta peptide-receptor for advanced glycation end product interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci USA 1997;94:5296-301.
52. 52 El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils [see comments]. Nature 1996;382:716-19.
53. 53 Honda M, Akiyama H, Yamada Y, Kondo H, Kawabe Y, Takeya M et al. Immunohistochemical evidence for a macrophage scavenger receptor in Mato cells and reactive microglia of ischemia and Alzheimer's disease. Biochem Biophys Res Commun 1998;245:734-40.
54. 54 Van Muiswinkel FL, Raupp SF, de Vos NM, Smits HA, Verhoef J, Eikelenboom P et al. The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages. J Neuroimmunol 1999;96:121-30.
55. 55 Smits HA, Van Muiswinkel FL, de Vos NM, Verhoef J et al. The amyloid-beta (1-42) -induced respiratory burst of primary human macrophages is enhanced in the presence of amyloid-beta (25-35). In: Iqbal K, Swaab DF, Winblad B, Wisniewski HM, editors. Alzheimer's Disease and Related Disorders. Chichester, Sussex: John Wiley & Sons Ltd.; 1999.p 457-61.
56. 56 Tanaka C, Kamata H, Takeshita H, Yagisawa H, Hirata H. Redox regulation of lipopolysaccharide (LPS) -induced interleukin-8 (IL-8) gene expression mediated by NF kappa B and AP-1 in human astrocytoma U373 cells. Biochem Biophys Res Commun 1997;232:568-73.
57. 57 Lieb K, Fiebich BL, Schaller H, Berger M, Bauer J. Interleukin-1 beta and tumor necrosis factor-alpha induce expression of alpha 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa B. J Neurochem 1996;67:2039-44.
58. 58 Akama KT, Albanese C, Pestell RG, Van Eldik LJ. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc Natl Acad Sci USA 1998;95:5795-800.
59. 59 Hu J, Akama KT, Krafft GA, Chromy BA, Van Eldik LJ. Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res 1998;785:195-206.
60. 60 Vincent VA, Tilders FJ, Van Dam AM. Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor beta. Glia 1997;19: 190-8.
61. 61 DeWitt DA, Perry G, Cohen M, Doller C, Silver J. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp Neurol 1998;149:329-40.
62. 62 Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089-93.
63. 63 Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19:517-24.
64. 64 Teo I, Veryard C, Barnes H, An SF, Jones M, Lantos PL et al. Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. J Virol 1997;71:2928-33.
65. 65 Nath A, Geiger J. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog Neurobiol 1998;54:19-33.
66. 66 Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995;38:755-62.
67. 67 Gendelman HE, Orenstein JM, Baca LM, WeiSeries B, Burger H, Kalter DC et al. The macrophage in the persistence and pathogenesis of HIV infection. AIDS 1989;3:475-95.
68. 68 Dickson DW, Mattiace LA, Kure K, Hutchins K, Lyman WD, Brosnan CF. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest 1991;64:135-56.
69. 69 Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, Farber JM et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 1993;33:576-82.
70. 70 Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992;31:349-60.
71. 71 Conant K, Garzino Demo A, Nath A, McArthur JC, Halliday W, Power C et al. Induction of monocyte chemo-attractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 1998;95:3117-21.
72. 72 Nuovo GJ, Alfieri ML. AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol Med 1996;2:358-66.
73. 73 Vitkovic L, da Cunha A, Tyor WR. Cytokine Expression and Pathogenesis in AIDS Brain. In: Price RW, Perry SW, editors. HIV,AIDS and the Brain. New York: Raven Press;1994.p.203-22.
74. 74 Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai QH et al. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 1996;156:1284-95.
75. 75 Boven LA, Gomes L, Hery C, Gray F, Verhoef J, Portegies P et al. Increased peroxynitrite activity in AIDS Dementia Complex: Implications for the neuropathogenesis of HIV-1 infection. J Immunol 1999;162:4319-27.
76. 76 Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K et al. Cytokines and Arachidonic Metabolites Produced during Human Immunodeficiency Virus (HIV) -infected Macrophage-Astroglia Interactions: Implications for the Neuropathogenesis of HIV Disease. J Exp Med 1992;176:1703-18.
77. 77 Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 1991;88:6368-71.
78. 78 Nottet HS, Bar DR, van Hassel H, Verhoef J, Boven LA. Cellular aspects of HIV-1 infection of macrophages leading to neuronal dysfunction in in vitro models for HIV-1 encephalitis. J Leukoc Biol 1997;62:107-16.
79. 79 Schmidtmayerova H, Nottet HS, Nuovo G, Raabe T, Flanagan CR, Dubrovsky L et al. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci USA 1996;93:700-4.
80. 80 Conant K, Tornatore C, Atwood W, Meyers K, Traub R, Major EO. In vivo and in vitro infection of the astrocyte by HIV-1. Adv Neuroimmunol 1994;4:287-9.
81. 81 Sharer LR, Saito Y, Epstein LG, Blumberg BM. Detection of HIV-1 DNA in pediatric AIDS brain tissue by two-step ISPCR. Adv Neuroimmunol 1994;4:283-5.
82. 82 Kleinschmidt A, Neumann M, Moller C, Erfle V, Brack Werner R. Restricted expression of HIV1 in human astrocytes: molecular basis for viral persistence in the CNS. Res Virol 1994;145:147-53.
83. 83 Conant K, Ma M, Nath A, Major EO. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J Virol 1996;70:1384-9.
84. 84 Zidovetzki R, Wang JL, Chen P, Jeyaseelan R, Hofman F. Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kina. AIDS Res Hum Retroviruses 1998;14:825-33.
85. 85 Chen P, Mayne M, Power C, Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J Biol Chem 1997;272:22385-8.
86. 86 Wyss-Coray T, Masliah E, Toggas SM, Rockenstein EM, Brooker MJ, Lee HS et al. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J Clin Invest 1996;97:789-98.
87. 87 Lannuzel A, Barnier JV, Hery C, Huynh VT, Guibert B, Gray F et al. Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann Neurol 1997;42:847-56.
88. 88 Shrikant P, Benos DJ, Tang LP, Benveniste EN. HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/ signal transducer and activator of transcription and protein kinase C signaling pathways, J Immunol 1996;156:1307-14.
89. 89 Popik W, Hesselgesser JE, Pitha PM. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J Virol 1998;72:6406-13.
90. 90 Mallat M, Chamak B. Brain macrophages: neurotoxic or neurotrophic effector cells? J Leukoc Biol 1994;56:416-22.
91. 91 Pechan PA, Chowdhury K, Seifert W. Free radicals induce gene expression of NGF and bFGF in rat astrocyte culture. Neuroreport 1992;3:469-72.
92. 92 Ballabriga J, Pozas E, Planas AM, Ferrer I. bFGF and FGFR-3 immunoreactivity in the rat brain following systemic kainic acid administration at convulsant doses: Localization of bFGF and FGFR-3 in reactive astrocytes, and FGFR-3 in reactive microglia. Brain Res 1997;752:315-18.
93. 93 Nottet HS, Jett M, Flanagan CR, Zhai QH, Persidsky Y, Rizzino A et al. A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J Immunol 1995;154:3567-81.
94. 94 Mucke L, Eddleston M. Astrocytes in infectious and immune-mediated diseases of the central nervous system. FASEB J 1993;7:1226-32.
95. 95 Rosenberg PA. Accumulation of extracellular glutamate and neuronal death in astrocyte-poor cortical cultures exposed to glutamine. Glia 1991;4:91-100.
96. 96 Breitner JC. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu Rev Med 1996;47:401-11.
97. 97 Breitner JC, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD et al. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging 1995;16:523-30.
98. 98 Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993;43:1609-11.
99. 99 Kiebburtz K, Dana Consortium on the Therapy of Dementia HIV and Related Cognitive Disorders. Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. Neurology 1997;49:142-6.
100. 100 Schifitto G, Sacktor N, Marder K, McDermott MP, McArthur JC, Kieburtz K et al. Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium. Neurology 1999;53:391-6.
101. 101 Lukiw WJ, Bazan NG. Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex. J Neurosci Res 1997;50:937-45.
102. 102 Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997;17:2746-55.
103. 103 Gendelman HE, Zheng J, Coulter CL, Ghorpade A, Che M, Thylin M et al. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J Infect Dis 1998;178:1000-7.
104. 104 Scott SA, Crutcher KA. Nerve growth factor and Alzheimer's disease. Rev Neurosci 1994;5:179-211.
105. 105 Yamada K, Nitta A, Hasegawa T, Fuji K, Hiramatsu M, Kameyama T et al. Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease. Behav Brain Res 1997;83:117-22.